Company news from the 09/12/06 News Brief

Share this article:
MedImmune broke ground on a $250 million, multi-phase expansion project at its Frederick, MD, manufacturing site. The expansion will increase MedImmune's manufacturing capacity for monoclonal antibodies including Synagis, which it introduced to the market in 1998 and other products in the company's pipeline.
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.